BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2198749)

  • 1. Ivermectin--clinical trials and treatment schedules in onchocerciasis.
    Brown KR; Neu DC
    Acta Leiden; 1990; 59(1-2):169-75. PubMed ID: 2198749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ivermectin in the treatment and prevention of human onchocerciasis].
    Larivière M; Beauvais B; Derouin F; Basset D; Basset A; Sarfati C
    Ann Med Interne (Paris); 1987; 138(1):49-51. PubMed ID: 3296903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in onchocerciasis patients after a single dose of ivermectin.
    Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
    N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
    Diallo S; Aziz MA; Lariviere M; Diallo JS; Diop-Mar I; N'Dir O; Badiane S; Py D; Schulz-Key H; Gaxotte P
    Trans R Soc Trop Med Hyg; 1986; 80(6):927-34. PubMed ID: 3299905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
    Awadzi K; Dadzie KY; Kläger S; Gilles HM
    Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
    Mwetta E; Hills E
    East Afr Med J; 1994 Dec; 71(12):790-1. PubMed ID: 7705249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis.
    White AT; Newland HS; Taylor HR; Erttmann KD; Keyvan-Larijani E; Nara A; Aziz MA; D'Anna SA; Williams PN; Greene BM
    J Infect Dis; 1987 Sep; 156(3):463-70. PubMed ID: 3302053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg].
    Larivière M; Beauvais B; Aziz M; Garin JF; Abeloos J; Derouin F; Bamba M; Bossebceuf C; Ferly-Therizol M; Sarfati C
    Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):35-47. PubMed ID: 2545366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of ivermectin in the control of onchocerciasis].
    Chippaux JP; Boussinesq M; Prod'hon J
    Sante; 1995; 5(3):149-58. PubMed ID: 7640897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose therapy with ivermectin for onchocerciasis.
    Greene BM; White AT; Newland HS; Keyvan-Larijani E; Dukuly ZD; Gallin MY; Aziz MA; Williams PN; Taylor HR
    Trans Assoc Am Physicians; 1987; 100():131-8. PubMed ID: 3455063
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human onchocerciasis and "sowda" in the Republic of Yemen].
    Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
    Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana.
    Awadzi K; Dadzie KY; Schulz-Key H; Gilles HM; Fulford AJ; Aziz MA
    Ann Trop Med Parasitol; 1986 Aug; 80(4):433-42. PubMed ID: 3539046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
    Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
    Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
    Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
    Fischer P; Kipp W; Kabwa P; Buttner DW
    Am J Trop Med Hyg; 1995 Aug; 53(2):171-8. PubMed ID: 7677220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.
    Dadzie KY; Awadzi K; Bird AC; Schulz-Key H
    Trop Med Parasitol; 1989 Sep; 40(3):355-60. PubMed ID: 2694314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parasitological efficacy of repeated treatments with ivermectin in an onchocerciasis focus in north Cameroon].
    Boussinesq M; Chippaux JP; Ernould JC; Prod'Hon J; Quillévéré D
    Bull Soc Pathol Exot; 1993; 86(2):112-5. PubMed ID: 8353468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.